IMATINIB
DrugBank ID: db00619
DrugCentral: imatinib
Synonymous :imatinib | imatinibum | α-(4-methyl-1-piperazinyl)-3’-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-toluidide
Drug Sentece Context
Table 1. Analysis of context sentence of imatinib gene in 1 abstracts.
| pmid | sentence |
|---|---|
| 32424293 | There was also an increased risk of developing COVID-19 in subjects in advanced phase CML (P = 0.004) even when they achieved a complete cytogenetic response or major molecular response at the time of exposure to SARS-CoV-2. 1 of 21 subjects receiving 3rd generation tyrosine kinase-inhibitor (TKI) developed COVID-19 versus 3 of 346 subjects receiving imatinib versus 0 of 162 subjects receiving 2nd generation TKIs (P = 0.096). |
| 32455090 | A 58-year-old female with a history of morbid obesity, HTN, gout, CML managed with imatinib, and chronic kidney disease presented as a transfer from a community hospital to our burn center. |
| 32513299 | Have used other anti-pulmonary fibrosis drugs in the past 14 days, such as nintedanib, pirfenidone, penicillamine, colchicine, tumor necrosis factor alpha blocker, imatinib, glucocorticoid hormones, morphomycodyl esters, azathioprine, cyclophosphamide, interferon-γ, and traditional Chinese medicine;6. |
| 32583086 | This review also highlights potential targets for prevention and therapy of COVID-19-related organ damage and discusses the role of marketed drugs, such as eculizumab and imatinib, as suitable candidates for clinical trials. |